Search results

Crohn's Disease Forum

Help Support Crohn's Disease Forum:

  1. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    Qu Biologics press release (July 23rd, 2019): https://www.qubiologics.com/qu-biologics-publishes-potentially-paradigm-shifting-results-of-their-first-randomized-placebo-controlled-trial-for-the-treatment-of-crohns-disease/ Others: https://www.qubiologics.com/news-investors/news/
  2. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

  3. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    A few years after my Crohn's diagnosis, I had oral and oropharyngeal candidiasis due to corticosteroid use. It didn't go away with liquid nystatin so I had to use a more systemic and powerful antifungal (fluconazole) to treat that. I found it interesting to find out that fluconazole was also...
  4. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    https://www.princeton.edu/news/2018/12/13/biologists-turn-eavesdropping-viruses-bacterial-assassins
  5. Crohn2357

    Anybody on 2 biologics

  6. Crohn2357

    Is Entyvio Effective At Treating Crohn's Flares?

    I think anti-tnfs and ustekinumab are much more preferable drugs than entyvio for Crohn's disease. Adding thiopurines (imuran or 6 mp) to the biologic therapy might make a positive difference. That's what I have been doing. kiny's writings in that thread, as well as the data from the clinical...
  7. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    https://crohnsforum.com/threads/interview-with-dr-hal-gunn-the-founding-ceo-of-qu-biologics-and-developer-of-site-specific-immunomodulation-ssi.43965/
  8. Crohn2357

    Entyvio (Vedolizumab) Support Group

    https://crohnsforum.com/threads/vedolizumab-brings-endoscopic-remission-in-some-patients-with-crohns-disease.85221/
  9. Crohn2357

    Is Entyvio Effective At Treating Crohn's Flares?

    https://crohnsforum.com/threads/vedolizumab-brings-endoscopic-remission-in-some-patients-with-crohns-disease.85221/
  10. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    https://crohnsforum.com/threads/manipulating-aiec-in-crohns-patients.79483/
  11. Crohn2357

    Using Stem Cells To Treat Perianal Fistulas

    https://www.crohnscolitisfoundation.org/personal-stories/brandons-story
  12. Crohn2357

    Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naïve Patients with Crohn’s Disease

    Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2017 Aug 1. Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Aug; 14(8): 1120–1129.e6. Published online 2016 Apr 4. doi: 10.1016/j.cgh.2016.03.038 PMCID: PMC4955682 NIHMSID: NIHMS776209 PMID: 27058635...
  13. Crohn2357

    Using Stem Cells To Treat Perianal Fistulas

    https://www.ncbi.nlm.nih.gov/pubmed/31049792 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212615/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107517/ https://www.ncbi.nlm.nih.gov/pubmed/29578916 https://www.ncbi.nlm.nih.gov/pubmed/30772343...
  14. Crohn2357

    The IBD Therapeutic Pipeline is Primed to Produce

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910475/
  15. Crohn2357

    The IBD Therapeutic Pipeline is Primed to Produce

    Combining different biologic drugs The availability of several biologic drugs for the treatment of IBD offers the possibility to combine these agents and simultaneously antagonise different pathways, potentially resulting in an additive or synergistic effects for refractory disease...
  16. Crohn2357

    The IBD Therapeutic Pipeline is Primed to Produce

    Comprehensive. http://www.practicalgastro-digital.com/practicalgastro/april_2019/MobilePagedArticle.action?articleId=1495927#articleId1495927
  17. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    http://www.crohnsmapvaccine.com/faq/
  18. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    Some videos explaining biofilms:
  19. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    Swidsinski's work has been discussed a lot in HW's UC board. Some of the threads: https://www.healingwell.com/community/default.aspx?f=38&m=2900617 https://www.healingwell.com/community/default.aspx?f=38&m=3322927 https://www.healingwell.com/community/default.aspx?f=38&m=2854282...
  20. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    More information: https://clinicaltrials.gov/ct2/show/NCT02620007 http://www.practicalgastro-digital.com/practicalgastro/april_2019/MobilePagedArticle.action?articleId=1495927#articleId1495927
Back
Top